Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Tight versus standard blood pressure control in patients with hypertension with and without cardiovascular disease.

Reboldi G, Angeli F, de Simone G, Staessen JA, Verdecchia P; Cardio-Sis Investigators.

Hypertension. 2014 Mar;63(3):475-82. doi: 10.1161/HYPERTENSIONAHA.113.02089. Epub 2013 Dec 16.

2.

Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial.

Verdecchia P, Staessen JA, Angeli F, de Simone G, Achilli A, Ganau A, Mureddu G, Pede S, Maggioni AP, Lucci D, Reboldi G; Cardio-Sis investigators.

Lancet. 2009 Aug 15;374(9689):525-33. doi: 10.1016/S0140-6736(09)61340-4. Erratum in: Lancet. 2009 Sep 12;374(9693):880.

PMID:
19683638
3.

The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy.

Verdecchia P, Angeli F, Cavallini C, Mazzotta G, Repaci S, Pede S, Borgioni C, Gentile G, Reboldi G.

J Hypertens. 2009 Aug;27(8):1697-704. doi: 10.1097/HJH.0b013e32832c0031.

PMID:
19424088
4.

Effects of barnidipine on blood pressure and left ventricular diastolic function in patients with hypertension and metabolic syndrome: A 12-week, open-label noncomparison study.

Angeli F, Repaci S, Borgioni C, Sardone M, Scotti A, Verdecchia P.

Curr Ther Res Clin Exp. 2008 Jun;69(3):207-20. doi: 10.1016/j.curtheres.2008.06.003.

5.

Is the definition of daytime and nighttime blood pressure prognostically relevant?

Verdecchia P, Angeli F, Sardone M, Borgioni C, Garofoli M, Reboldi G.

Blood Press Monit. 2008 Jun;13(3):153-5. doi: 10.1097/MBP.0b013e3282fd1709.

PMID:
18496291
6.

Prognostic value of circadian blood pressure changes in relation to differing measures of day and night.

Verdecchia P, Angeli F, Borgioni C, Repaci S, Guerrieri M, Andreani F, Garofoli M, Reboldi G.

J Am Soc Hypertens. 2008 Mar-Apr;2(2):88-96. doi: 10.1016/j.jash.2007.10.003.

PMID:
20409890
7.

The clinical significance of white-coat and masked hypertension.

Verdecchia P, Angeli F, Gattobigio R, Borgioni C, Castellani C, Sardone M, Reboldi G.

Blood Press Monit. 2007 Dec;12(6):387-9. doi: 10.1097/MBP.0b013e32824958e5. Review.

PMID:
18277317
8.
9.

Ambulatory blood pressure and cardiovascular outcome in relation to perceived sleep deprivation.

Verdecchia P, Angeli F, Borgioni C, Gattobigio R, Reboldi G.

Hypertension. 2007 Apr;49(4):777-83. Epub 2007 Jan 29.

10.

Prognostic value of lipoprotein fractions in essential hypertension.

Verdecchia P, Reboldi G, Angeli F, Gattobigio R, Borgioni C, Filippucci L, Poeta F, Porcellati C.

Blood Press. 2004;13(5):295-303.

PMID:
15545153
11.

Validation of the A&D UA-774 (UA-767Plus) device for self-measurement of blood pressure.

Verdecchia P, Angeli F, Poeta F, Reboldi GP, Borgioni C, Pittavini L, Porcellati C.

Blood Press Monit. 2004 Aug;9(4):225-9.

PMID:
15311150
12.

Adverse prognostic significance of new diabetes in treated hypertensive subjects.

Verdecchia P, Reboldi G, Angeli F, Borgioni C, Gattobigio R, Filippucci L, Norgiolini S, Bracco C, Porcellati C.

Hypertension. 2004 May;43(5):963-9. Epub 2004 Mar 22.

13.

Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis.

Verdecchia P, Angeli F, Borgioni C, Gattobigio R, de Simone G, Devereux RB, Porcellati C.

Am J Hypertens. 2003 Nov;16(11 Pt 1):895-9.

PMID:
14573325
14.

Improved cardiovascular risk stratification by a simple ECG index in hypertension.

Verdecchia P, Angeli F, Reboldi G, Carluccio E, Benemio G, Gattobigio R, Borgioni C, Bentivoglio M, Porcellati C, Ambrosio G.

Am J Hypertens. 2003 Aug;16(8):646-52.

PMID:
12878370
15.

Atrial fibrillation in hypertension: predictors and outcome.

Verdecchia P, Reboldi G, Gattobigio R, Bentivoglio M, Borgioni C, Angeli F, Carluccio E, Sardone MG, Porcellati C.

Hypertension. 2003 Feb;41(2):218-23.

16.

Prevalent influence of systolic over pulse pressure on left ventricular mass in essential hypertension.

Verdecchia P, Schillaci G, Borgioni C, Gattobigio R, Ambrosio G, Porcellati C.

Eur Heart J. 2002 Apr;23(8):658-65.

PMID:
11969281
17.

Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension.

Verdecchia P, Porcellati C, Reboldi G, Gattobigio R, Borgioni C, Pearson TA, Ambrosio G.

Circulation. 2001 Oct 23;104(17):2039-44.

18.
19.

Value of a simple echocardiographic linear predictor of left ventricular mass in systemic hypertension.

Verdecchia P, Reboldi G, Schillaci G, Borgioni C, Ciucci A, Telera MP, Ambrosio G, Porcellati C.

Am J Cardiol. 1999 Nov 15;84(10):1209-14.

PMID:
10569332
20.

Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension.

Verdecchia P, Reboldi G, Schillaci G, Borgioni C, Ciucci A, Telera MP, Santeusanio F, Porcellati C, Brunetti P.

Circulation. 1999 Oct 26;100(17):1802-7.

Supplemental Content

Loading ...
Support Center